Tofacitinib Tablet, Film Coated, Extended Release
Product Images NDC 73190-102

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tofacitinib (NDC 73190-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (102 30)

FDA Label Image

Figure1.jpg (Figure1)

This text provides information on factors such as weight, age, and medical conditions like renal impairment and hepatic impairment. It also mentions the demographics of the individual, including being female, Asian, Black, and Hispanic. Additionally, it presents ratios and 90% confidence intervals for different factors.*

FDA Label Image

Figure2.jpg (Figure2)

This text appears to be a list of coadministered drugs and their interactions as substrates. It mentions drugs such as Methotrexate, Midazolam, Oral Contraceptives (Levonorgestrel, Ethinyl Estradiol), and Metformin. PK parameters such as AUC and Cmax are included along with ratios and confidence intervals. The data may be related to drug-drug interactions and their effects on pharmacokinetics.*

FDA Label Image

Figure3.jpg (Figure3)

FDA Label Image

Figure4.jpg (Figure4)

FDA Label Image

Figure5.jpg (Figure5)

FDA Label Image

Figure6.jpg (Figure6)

FDA Label Image

Structure.jpg (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.